Zacks Investment Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-132,307
Closed -$6.26M 798
2025
Q4
$6.26M Sell
132,307
-2,900
-2% -$134K 0.05% 204
2025
Q3
$6M Buy
135,207
+742
+0.6% +$35.5K 0.05% 206
2025
Q2
$6.45M Buy
+134,465
New +$5.85M 0.06% 199
2021
Q3
Sell
-45,988
Closed -$2.36M 642
2021
Q2
$2.36M Buy
45,988
+2,833
+7% +$146K 0.04% 269
2021
Q1
$2.22M Buy
43,155
+4,970
+13% +$273K 0.04% 269
2020
Q4
$2.14M Buy
38,185
+1,635
+4% +$87.3K 0.04% 252
2020
Q3
$2.02M Buy
36,550
+3,077
+9% +$160K 0.04% 224
2020
Q2
$1.52M Buy
+33,473
New +$1.5M 0.03% 239

Other funds holding QGEN

Zacks Investment Management's QGEN Position: Q1 2026 in Review

Zacks Investment Management sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 132,307 shares — an estimated $6.26M sold.

Zacks Investment Management first reported a position in QGEN in Q2 2020 and held it in 8 quarters. The position peaked at $6.45M in Q2 2025. 346 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Zacks Investment Management reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
  • Zacks Investment Management sold 132,307 Qiagen shares in Q1 2026, an estimated $6.26M.
  • Zacks Investment Management first reported a position in Qiagen in Q2 2020 and held it in 8 quarters.
  • Zacks Investment Management's Qiagen position peaked at $6.45M in Q2 2025.
  • 346 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.